N12 An evaluation of the impact of IBDoc in clinical practice 5 years after introduction
K. Sugrue, S. Gleeson, J. McCarthy, M. Buckley
Mercy University Hospital, Department of Gastroenterology, Cork, Ireland
Background
Faecal Calprotectin is a well-established biomarker to measure the level of inflammation in the gut. Assessment of calprotectin is important to measure disease activity, effectiveness of treatments as well as predicting relapses in inflammatory bowel disease (IBD). IB
Methods
IB
Results
Of the 240 tests performed 40% had a normal result, 40% were moderate and 20% were high. All of the normal results avoided clinic appointments which freed up clinic time for patients with active disease and resulted in cost savings for the hospital. 70% of these patients were deemed suitable for future Virtual Clinics which resulted in further cost savings and freed up Consultant time. The majority of patients 60% had moderate or high results. The 20% of results that were high were all booked for urgent colonoscopy. All of the moderate results were fast tracked to clinic and 20% of these had a change of medical therapy.
Conclusion
This study shows the benefits of using IB